Paradigm Biopharmaceuticals Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Paradigm Biopharmaceuticals Ltd with three other
companies in this sector in AUSTRALIA :
Invion Limited
(2020
sales of 3.48 million Australian Dollars [US$2.69 million]
of which 100%
was Drug Development),
Medlab Clinical Ltd
(5.37 million Australian Dollars [US$4.16 million]
of which 67%
was Pharmaceutical Research), and
Imugene Limited
(4.21 million Australian Dollars [US$3.26 million]
of which 100%
was Health technologies).
Sales Analysis.
Paradigm Biopharmaceuticals Ltd reported sales of A$4.70 million (US$3.64 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 44.7%
versus 2019, when the company's sales were A$3.25 million.
Sales at Paradigm Biopharmaceuticals Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 63,950%).